SEARCH

SEARCH BY CITATION

References

  • Aaron SD, Ferris W, Ramotar K, Vandemheen K, Chan F & Saginur R (2002) Single and combination antibiotic susceptibilities of planktonic, adherent, and biofilm-grown Pseudomonas aeruginosa isolates cultured from sputa of adults with cystic fibrosis. J Clin Microbiol 40: 41724179.
  • Aiassa V, Barnes AI & Albesa I (2006) Action of ciprofloxacin on planktonic bacteria and biofilm of Proteus mirabilis. Biofilms 3: 1117.
  • Aiello AE, Larson EL & Levy SB (2007) Consumer antibacterial soaps: effective or just risky? Clin Infect Dis 45 (suppl 2): S137S147.
  • Alekshun MN & Levy SB (1997) Regulation of chromosomally mediated multiple antibiotic resistance: the mar regulon. Antimicrob Agents Ch 41: 20672075.
  • Allmyr M, Adolfsson-Erici M, McLachlan MS & Sandborgh-Englund G (2006) Triclosan in plasma and milk from Swedish nursing mothers and their exposure via personal care products. Sci Total Environ 372: 8793.
  • Allmyr M, Harden F, Toms LM, Mueller JF, McLachlan MS, Adolfsson-Erici M & Sandborgh-Englund G (2008) The influence of age and gender on triclosan concentrations in Australian human blood serum. Sci Total Environ 393: 162167.
  • Anderl JN, Franklin MJ & Stewart PS (2000) Role of antibiotic penetration limitation in Klebsiella pneumoniae biofilm resistance to ampicillin and ciprofloxacin. Antimicrob Agents Ch 44: 18181824.
  • Anderl JN, Zahller J, Roe F & Stewart PS (2003) Role of nutrient limitation and stationary-phase existence in Klebsiella pneumoniae biofilm resistance to ampicillin and ciprofloxacin. Antimicrob Agents Ch 47: 12511256.
  • Braoudaki M & Hilton AC (2004a) Low level of cross-resistance between triclosan and antibiotics in Escherichia coli K-12 and E. coli O55 compared to E. coli O157. FEMS Microbiol Lett 235: 305309.
  • Braoudaki M & Hilton AC (2004b) Adaptive resistance to biocides in Salmonella enterica and Escherichia coli O157 and cross-resistance to antimicrobial agents. J Clin Microbiol 42: 7378.
  • Chou TC (2006) Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies. Pharmacol Rev 58: 621681.
  • Chuanchuen R, Beinlich K, Hoang TT, Becher A, Karkhoff-Schweizer RR & Schweizer HP (2001) Cross-resistance between triclosan and antibiotics in Pseudomonas aeruginosa is mediated by multidrug efflux pumps: exposure of a susceptible mutant strain to triclosan selects nfxB mutants overexpressing MexCD-OprJ. Antimicrob Agents Ch 45: 428432.
  • Cohen SP, McMurry LM, Hooper DC, Wolfson JS & Levy SB (1989) Cross-resistance to fluoroquinolones in multiple-antibiotic-resistant (Mar) Escherichia coli selected by tetracycline or chloramphenicol: decreased drug accumulation associated with membrane changes in addition to OmpF reduction. Antimicrob Agents Ch 33: 13181325.
  • Crump JA, Barrett TJ, Nelson JT & Angulo FJ (2003) Reevaluating fluoroquinolone breakpoints for Salmonella enterica serotype Typhi and for non-Typhi salmonellae. Clin Infect Dis 37: 7581.
  • Desai M, Buhler T, Weller PH & Brown MR (1998) Increasing resistance of planktonic and biofilm cultures of Burkholderia cepacia to ciprofloxacin and ceftazidime during exponential growth. J Antimicrob Chemoth 42: 153160.
  • Ferrero L, Cameron B, Manse B, Lagneaux D, Crouzet J, Famechon A & Blanche F (1994) Cloning and primary structure of Staphylococcus aureus DNA topoisomerase IV: a primary target of fluoroquinolones. Mol Microbiol 13: 641653.
  • George AM & Levy SB (1983) Amplifiable resistance to tetracycline, chloramphenicol, and other antibiotics in Escherichia coli: involvement of a non-plasmid-determined efflux of tetracycline. J Bacteriol 155: 531540.
  • Gerstel U & Romling U (2001) Oxygen tension and nutrient starvation are major signals that regulate agfD promoter activity and expression of the multicellular morphotype in Salmonella typhimurium. Environ Microbiol 3: 638648.
  • Guillen J, Bernabeu A, Shapiro S & Villalain J (2004) Location and orientation of triclosan in phospholipid model membranes. Eur Biophys J 33: 448453.
  • Hachler H, Cohen SP & Levy SB (1991) marA, a regulated locus which controls expression of chromosomal multiple antibiotic resistance in Escherichia coli. J Bacteriol 173: 55325538.
  • Heath RJ, Li J, Roland GE & Rock CO (2000) Inhibition of the Staphylococcus aureus NADPH-dependent enoyl–acyl carrier protein reductase by triclosan and hexachlorophene. J Biol Chem 275: 46544659.
  • Helms M, Vastrup P, Gerner-Smidt P & Molbak K (2002) Excess mortality associated with antimicrobial drug-resistant Salmonella typhimurium. Emerg Infect Dis 8: 490495.
  • Helms M, Simonsen J & Molbak K (2004) Quinolone resistance is associated with increased risk of invasive illness or death during infection with Salmonella serotype Typhimurium. J Infect Dis 190: 16521654.
  • Kaatz GW, Seo SM & Ruble CA (1993) Efflux-mediated fluoroquinolone resistance in Staphylococcus aureus. Antimicrob Agents Ch 37: 10861094.
  • Karatzas KA, Webber MA, Jorgensen F, Woodward MJ, Piddock LJ & Humphrey TJ (2007) Prolonged treatment of Salmonella enterica serovar Typhimurium with commercial disinfectants selects for multiple antibiotic resistance, increased efflux and reduced invasiveness. J Antimicrob Chemoth 60: 947955.
  • Kolpin DW, Furlong ET, Meyer MT, Thurman EM, Zaugg SD, Barber LB & Buxton HT (2002) Pharmaceuticals, hormones, and other organic wastewater contaminants in U.S. streams, 1999–2000: a national reconnaissance. Environ Sci Technol 36: 12021211.
  • Larson E, Aiello A, Lee LV, Della-Latta P, Gomez-Duarte C & Lin S (2003) Short- and long-term effects of handwashing with antimicrobial or plain soap in the community. J Commun Health 28: 139150.
  • Levy CW, Roujeinikova A, Sedelnikova S, Baker PJ, Stuitje AR, Slabas AR, Rice DW & Rafferty JB (1999) Molecular basis of triclosan activity. Nature 398: 383384.
  • Mazzariol A, Tokue Y, Kanegawa TM, Cornaglia G & Nikaido H (2000) High-level fluoroquinolone-resistant clinical isolates of Escherichia coli overproduce multidrug efflux protein AcrA. Antimicrob Agents Ch 44: 34413443.
  • McMurry LM, Oethinger M & Levy SB (1998a) Triclosan targets lipid synthesis. Nature 394: 531532.
  • McMurry LM, Oethinger M & Levy SB (1998b) Overexpression of marA, soxS, or acrAB produces resistance to triclosan in laboratory and clinical strains of Escherichia coli. FEMS Microbiol Lett 166: 305309.
  • Meade MJ, Waddell RL & Callahan TM (2001) Soil bacteria Pseudomonas putida and Alcaligenes xylosoxidans subsp. denitrificans inactivate triclosan in liquid and solid substrates. FEMS Microbiol Lett 204: 4548.
  • Miller PF, Gambino LF, Sulavik MC & Gracheck SJ (1994) Genetic relationship between soxRS and mar loci in promoting multiple antibiotic resistance in Escherichia coli. Antimicrob Agents Ch 38: 17731779.
  • Molbak K (2005) Human health consequences of antimicrobial drug-resistant Salmonella and other foodborne pathogens. Clin Infect Dis 41: 16131620.
  • Nole G, Johnson A, Znaiden A & Resch C (2000) Antibacterial lotion testing: a practical approach to demonstrate the antibacterial efficacy of a triclosan-containing leave-on moisturizer. Int J Cosmetics Sci 22: 341347.
  • Okusu H, Ma D & Nikaido H (1996) AcrAB efflux pump plays a major role in the antibiotic resistance phenotype of Escherichia coli multiple-antibiotic-resistance (Mar) mutants. J Bacteriol 178: 306308.
  • Randall LP, Cooles SW, Piddock LJ & Woodward MJ (2004) Effect of triclosan or a phenolic farm disinfectant on the selection of antibiotic-resistant Salmonella enterica. J Antimicrob Chemoth 54: 621627.
  • Regos J, Zak O, Solf R, Vischer WA & Weirich EG (1979) Antimicrobial spectrum of triclosan, a broad-spectrum antimicrobial agent for topical application. II. Comparison with some other antimicrobial agents. Dermatologica 158: 7279.
  • Reiss R, Lewis G & Griffin J (2009) An ecological risk assessment for triclosan in the terrestrial environment. Environ Toxicol Chem 28: 15461556.
  • Rodriguez-Martinez JM, Ballesta S & Pascual A (2007) Activity and penetration of fosfomycin, ciprofloxacin, amoxicillin/clavulanic acid and co-trimoxazole in Escherichia coli and Pseudomonas aeruginosa biofilms. Int J Antimicrob Ag 30: 366368.
  • Romling U, Rohde M, Olsen A, Normark S & Reinkoster J (2000) AgfD, the checkpoint of multicellular and aggregative behaviour in Salmonella typhimurium regulates at least two independent pathways. Mol Microbiol 36: 1023.
  • Rupali P, Abraham OC, Jesudason MV, John TJ, Zachariah A, Sivaram S & Mathai D (2004) Treatment failure in typhoid fever with ciprofloxacin susceptible Salmonella enterica serotype Typhi. Diagn Micr Infec Dis 49: 13.
  • Russell AD (2004) Whither triclosan? J Antimicrob Chemoth 53: 693695.
  • Scher K, Romling U & Yaron S (2005) Effect of heat, acidification, and chlorination on Salmonella enterica serovar Typhimurium cells in a biofilm formed at the air-liquid interface. Appl Environ Microb 71: 11631168.
  • Scher K, Kesselman E, Shimoni E & Yaron S (2007) Morphological analysis of young and old pellicles of Salmonella Typhimurium. Biofouling 23: 385394.
  • Schweizer H (2001) Antibiotic and biocide and its link to antibiotics. J Hosp Infect 43: 17.
  • Singer H, Muller S, Tixier C & Pillonel L (2002) Triclosan: occurrence and fate of a widely used biocide in the aquatic environment: field measurements in wastewater treatment plants, surface waters, and lake sediments. Environ Sci Technol 36: 49985004.
  • Slinger R, Desjardins M, McCarthy AE, Ramotar K, Jessamine P, Guibord C & Toye B (2004) Suboptimal clinical response to ciprofloxacin in patients with enteric fever due to Salmonella spp. with reduced fluoroquinolone susceptibility: a case series. BMC Infect Dis 4: 36.
  • Tabak M, Scher K, Hartog E, Romling U, Matthews KR, Chikindas ML & Yaron S (2007) Effect of triclosan on Salmonella typhimurium at different growth stages and in biofilms. FEMS Microbiol Lett 267: 200206.
  • Takahashi H, Kikuchi T, Shoji S, Fujimura S, Lutfor AB, Tokue Y, Nukiwa T & Watanabe A (1998) Characterization of gyrA, gyrB, grlA and grlB mutations in fluoroquinolone-resistant clinical isolates of Staphylococcus aureus. J Antimicrob Chemoth 41: 4957.
  • Tkachenko O, Shepard J, Aris VM, Joy A, Bello A, Londono I, Marku J, Soteropoulos P & Peteroy-Kelly MA (2007) A triclosan-ciprofloxacin cross-resistant mutant strain of Staphylococcus aureus displays an alteration in the expression of several cell membrane structural and functional genes. Res Microbiol 158: 651658.
  • Villalain J, Mateo CR, Aranda FJ, Shapiro S & Micol V (2001) Membranotropic effects of the antibacterial agent Triclosan. Arch Biochem Biophys 390: 128136.
  • Webber MA, Coldham NG, Woodward MJ & Piddock LJ (2008a) Proteomic analysis of triclosan resistance in Salmonella enterica serovar Typhimurium. J Antimicrob Chemoth 62: 9297.
  • Webber MA, Randall LP, Cooles S, Woodward MJ & Piddock LJ (2008b) Triclosan resistance in Salmonella enterica serovar Typhimurium. J Antimicrob Chemoth 62: 8391.
  • Yazdankhah SP, Scheie AA, Hoiby EA, Lunestad BT, Heir E, Fotland TO, Naterstad K & Kruse H (2006) Triclosan and antimicrobial resistance in bacteria: an overview. Microb Drug Resist 12: 8390.
  • Yoshida H, Bogaki M, Nakamura S, Ubukata K & Konno M (1990) Nucleotide sequence and characterization of the Staphylococcus aureus norA gene, which confers resistance to quinolones. J Bacteriol 172: 69426949.
  • Zogaj X, Nimtz M, Rohde M, Bokranz W & Romling U (2001) The multicellular morphotypes of Salmonella typhimurium and Escherichia coli produce cellulose as the second component of the extracellular matrix. Mol Microbiol 39: 14521463.